
即时询价 ×
* 必填项
请填妥以下表格,您将在一分钟内得到邮件机器人给你的报价。
Inquiry Online
×
* Required Fields.
Please complete the form below and we will contact you shortly.
Bulk Inquiry
×
* Required Fields.
Please complete the form below and we will contact you shortly.

CAS号 | 175865-59-5 | 货号 | BCP08146 |
中文名 | 缬更昔洛韦盐酸盐 | ||
英文名 | Valganciclovir hydrochloride | ||
中文别名 | |||
英文别名 | |||
SMILES | |||
化学名称 | |||
分子式 | C14H23ClN6O5 | 分子量 | 390.83 |
纯度 | 98% | 配送 | 惯例下常温包邮 |
产品描述 | in vitro: In cell culture model systems using Caco-2 cells for PEPT1 and SKPT cells for PEPT2, valganciclovir inhibited glycylsarcosine transport mediated by PEPT1 and PEPT2 with K(i) values (inhibition constant) of 1.68+/-0.30 and 0.043+/- 0.005 mM, respectively. The inhibition by valganciclovir was competitive in both cases . in vivo: 37 patients were enrolled; 19 patients received treatment with VGV and 18 patients received treatment with GCV. The VGV was not inferior in efficacy to GCV as pre-emptive therapy, with rates of viral clearance at 28 days of 89.5% and 83%, respectively (P-value for non-inferiority = 0.030). Toxicities were similar between the 2 arms. No patients developed CMV disease [2]. Patients being treated with an alemtuzumab-containing regimen received prophylaxis with either valaciclovir 500 mg orally daily orvalganciclovir 450 mg orally twice daily. None of the 20 patients randomized to valganciclovir experienced CMV reactivation (P = .004) . |
Tags:Valganciclovir hydrochloride 供应商,Valganciclovir hydrochloride 购买,Valganciclovir hydrochloride 生产,Valganciclovir hydrochloride 批量,Valganciclovir hydrochloride 供应,Valganciclovir hydrochloride 订购,Valganciclovir hydrochloride 采购